ARTICLE | Finance
MPM keeps building
How MPM is deploying three investment vehicles to support company building
February 22, 2019 10:55 PM UTC
MPM Capital’s new $400 million BioVentures 2018 fund will complement the firm’s cancer-focused initiatives and enable it to continue its company building strategy.
BioVentures 2018 closed on Feb. 21 and follows in the footsteps of BioVentures 2014 fund, which closed at $400 million in 2015 with a focus on building startups (see “New (Bio)Ventures at MPM”)...